Spyglass Pharma Logo - Long.png
SpyGlass Pharma Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with Glaucoma
April 02, 2024 08:00 ET | SpyGlass Pharma, Inc.
  Share Mean intraocular pressure (IOP) reduction from washed-out baseline was 44.6% at Month 12; all patients had IOP reduction >20% and IOP ≤ 18 mmHg. 100% of patients remained off topical...
Margot Goodkin -  Headshot
SpyGlass Pharma Strengthens Leadership to Further Advance its Intraocular Drug Delivery Platform
December 05, 2023 09:00 ET | SpyGlass Pharma, Inc.
Margot Goodkin, M.D., Ph.D., appointed Chief Medical OfficerBilal Khan, MBA, CEO of New World Medical, appointed to the SpyGlass Board of Directors ALISO VIEJO, Calif., Dec. 05, 2023 (GLOBE...
22157.jpg
Ocular Hypertension Pipeline Research Report 2023: Comprehensive Insights About 70+ Companies and 75+ Pipeline Drugs
November 24, 2023 05:43 ET | Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "Ocular Hypertension - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Ocular Hypertension - Pipeline...
Spyglass Pharma Logo - Long.png
SpyGlass Pharma Initiates Phase I/II Clinical Trial of its Intraocular Drug Delivery Platform
October 31, 2023 07:00 ET | SpyGlass Pharma, Inc.
ALISO VIEJO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, announced today the initiation of a Phase I/II clinical trial...
spyglass.png
SpyGlass Pharma Unveils 6-Month Data from the First-In-Human Trial of Its Innovative Drug Delivery Platform for Chronic Eye Conditions
February 03, 2023 11:15 ET | SpyGlass Pharma, Inc.
ALISO VIEJO, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic therapeutics company, released 6-month data from a First-in-Human glaucoma treatment trial showing...
22157.jpg
Global Antiglaucoma Drugs Market Research Report 2021
July 15, 2021 06:48 ET | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Antiglaucoma Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global Ocular Drug Delivery Market Overview with Technology Profiles of 50+ Companies Including AesculaTech, AesculaTech, Eximore Ltd., Grayburg Vision and More
December 24, 2020 04:28 ET | Research and Markets
Dublin, Dec. 24, 2020 (GLOBE NEWSWIRE) -- The "Ocular Drug Delivery: Market Overview, Delivery Technologies and Partnering Opportunities, 2nd edition" report has been added to...